Pembrolizumab,Pemetrexed,Cisplatin,bevacizumab
Merck,roche
['great work', 'beva ']
great to see ind.227: long awaited. chemo-pbro vs chemo. mostly epithel subtyp. 61% cps+ os improved hr0.79, 16 to17mo median; pfs benefit. cps not predictive. great work will the addition of beva improve this? let s see #asco23 
Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own.